TG Therapeutics (TGTX) and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI
Go back to TG Therapeutics (TGTX) and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI| TG THERAP (NASDAQ: TGTX) | Delayed: 55.80 -0.18 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.98 | 52 Week High | $14.87 | |||
| Open | $55.34 | 52 Week Low | $4.90 | |||
| Day High | $55.93 | P/E | N/A | |||
| Day Low | $54.09 | EPS | $-0.67 | |||
| Volume | 730,674 | |||||

